Specialty Pharma Partnering Yearbook 2013

1
Specialty Pharma Partnering Yearbook 2013
 

• Bharat Book Bureau

2
Summary

• The Specialty Pharma Partnering Yearbook 2013
  report series provides comprehensive
  understanding and unprecedented access to the
  partnering deals and agreements entered into by
  the worlds leading healthcare companies during
  2012.Using these reports, dealmakers will
  effectively and efficiently gain insight into the
  partnering activities of the past year. The
  report series allows you to view all the
  partnering and alliances deals announced
  worldwide.The initial chapters of this report
  provide an orientation of 2012s dealmaking and
  business activities.

3
Continue

• Chapter 1 provides an overview of the trends
  in dealmaking during 2012 covering trends by deal
  type, stage of development, technology type and
  therapeutic indication.Chapter 2 provides a
  review of the leading deals during 2012. Deals
  are listed by headline value, signed by bigpharma
  and bigbiotech, and most active bigpharma. Where
  the deal has an agreement contract published at
  the SEC a link provides online access to the
  contract.Chapter 3 provides a comprehensive
  listing of the top 50 bigpharma companies with a
  brief summary followed by a comprehensive listing
  of 2012 deals, as well as contract documents
  available in the public domain. Each deal title
  links via Weblink to an online version of the
  deal record and where available, the contract
  document, providing easy access to each contract
  document on demand.

4
Continue

• Chapter 4 provides a comprehensive
  directory of all partnering deals announced
  during 2012. The chapter is organized by
  company A-Z, stage of development at signing,
  deal type (collaborative RD, co-promotion,
  licensing etc), therapy area and technology type.
  Each deal title links via Weblink to an online
  version of the deal record and where available,
  the contract document, providing easy access to
  each contract document on demand.The report
  series also includes numerous tables and figures
  that illustrate the trends and activities in
  bigpharma partnering and dealmaking during
  2012.In conclusion, this report provides
  everything a prospective dealmaker needs to know
  about partnering in the research, development and
  commercialization of technologies and products
  during 2012.

5
Continue

• Key benefitsSpecialty Pharma Partnering
  Yearbook 2013 series provides the reader with the
  following key benefits
• In-depth understanding of recent dealmaking
  trends during 2012
• Comprehensive access to all deals entered into by
  the worlds biopharma companies during 2012
• Detailed access to actual partnership deals and
  contracts entered into by the leading fifty
  bigpharma companies
• Understand the key deal terms companies have
  agreed in previous deals
• Undertake due diligence to assess suitability of
  your proposed deal terms for partner companies

6
Continue

• Report scopeSpecialty Pharma Partnering
  Yearbook 2013 series is intended to provide the
  reader with an in-depth understanding and access
  to parthering and MA trends and structure of
  deals entered into by leading companies
  worldwide.Specialty Pharma Partnering Yearbook
  2013 includes
• Trends in dealmaking in the biopharma industry
  during 2012
• Comprehensive directory of partnering deals in
  2012
• Links to online access to all deals and
  alliances
• The leading partnering deals by value in 2012
• Most active partnering dealmakers during 2012

7
Continue

• In Specialty Pharma Partnering Yearbook
  2012 series the partnering and MA deals are
  listed by
• Company A-Z
• Headline value
• Stage of development at signing
• Deal component type
• Therapy area
• Technology type
• Each deal title links via Weblink to an
  online version of the deal record at Current
  Agreements and where available, the contract
  document, providing easy access to each contract
  document on demand.

8
Table Of Contents

• Executive SummaryChapter 1 Trends in
  dealmaking during 20121.1. Bigpharma dealmaking
  activity1.2. Partnering by deal type1.3.
  Partnering by industry sector1.4. Partnering by
  stage of development1.5. Partnering by
  technology type1.6. Partnering by therapy
  areaChapter 2 Leading deals during 20122.1.
  Introduction2.2. Top deals by value during 2012

9
For More Information You Can Visit-

• http//www.bharatbook.com/healthcare-market-
  research-reports/specialty-pharma-partnering-yearb
  ook-2013.html
• Or visit us at
• Bharat Book
  Bureau Phone
  91 22 27810772, 27810773
  Fax [phone]
  E-mail info_at_bharatbook.com
  Website
  www.bharatbook.com
  Twitter https//twitter.com/BharatBook
  Blog
  http//www.bharatbook.com/market-reports-blog/